No Data
No Data
Envoy Medical Q1 2024 GAAP EPS $(0.32), Sales $59.00K Miss $100.00K Estimate
Envoy Medical (NASDAQ:COCH) reported quarterly losses of $(0.32) per share. The company reported quarterly sales of $59.00 thousand which missed the analyst consensus estimate of $100.00 thousand by
Envoy Medical 1Q Rev $59,000 >COCH
Envoy Medical 1Q Rev $59,000 >COCH
Earnings Flash (COCH) ENVOY MEDICAL Reports Q1 Revenue $59,000
04:06 PM EDT, 05/15/2024 (MT Newswires) -- Earnings Flash (COCH) ENVOY MEDICAL Reports Q1 Revenue $59,000
10-Q: Quarterly report
How Envoy Medical Is Disrupting the Hearing Loss Industry
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell sharply during Monday's session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic d
No Data